Great news! The NAD+ Mouse Project has passed its second fundraising stretch goal, which means that the experiment will greatly expand its scope.


The research team will now have enough funding to buy enough NMN to conduct long-term studies on its effects on health and the aging processes. The project will monitor the mice for up to two years and collect a huge amount of data about their health, cognition, and aging, and it is the first longevity study of NMN in normally aging mice.

Can NMN delay or reverse the aging process in mice? This study is a solid step towards answering that question, and the data collected here could also potentially be used to support the ongoing human trial happening at Brigham and Women’s Hospital.

This success also shows the will of the community to support and drive scientific research on aging and really help to push the boundaries of knowledge. We are a growing community, and, as the technologies, we all want to arrive are now beginning to enter human trials, more and more people are taking up the torch to support healthier, longer lives free from age-related diseases. The prospect of ending age-related diseases in the next few decades seems to now be within striking distance, and everyone who has donated to this and other projects on has helped to make that day arrive sooner.

A special thank you to Sonal Alla, The Global Foundation for Human Aging Research, David Chambers, and the 10k donor who helped the project smash its initial goal in the first 48 hours of the campaign!

We would like to thank the community for its support, and, with over 260 backers for this project, that is a great amount of support indeed. The project has, at this moment, raised $63,000 to launch the experiment at Harvard Medical School, and there are still three more days left if you would like to donate and grab some of the cool donor rewards available through the fundraiser.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
  1. February 11, 2019

    Good work

Write a comment:

Cancel reply


Your email address will not be published.

Privacy Policy / Terms Of Use

       Powered by MMD